We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

Fund managers haven’t disclosed any holdings of SCMP yet.

SCMP Hedge Fund Activity: Q2 2018 in Review

0 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q2 2018, worth a combined $0 — down 100% from $21K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SCMP and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Glenmede Trust, exiting entirely with an estimated $8K sold.

  • 0 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q2 2018, down from 3 in Q1 2018.
  • Funds reported $0 of Sucampo Pharmaceuticals, Inc. stock for Q2 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q2 2018 and 3 closed out, a net change of -3 holders.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q2 2018 was Glenmede Trust, an estimated $8K sold.

Based on aggregated 13F filings for Q2 2018.